Susan E. Quaggin, MD, FASN, Councilor
Susan E. Quaggin, MD, FASN, is a graduate of the University of Toronto where she completed her residency and served as chief medical resident for the University’s St. Michael’s Hospital. She completed her nephrology fellowship at the University of Toronto and Yale University, where she also completed research and post-doctoral training. Dr. Quaggin also trained in the developmental biology program at the University of Toronto's Samuel Lunenfeld Research Institute.
Dr. Quaggin’s research interests include a focus on fundamental genetic pathways required to establish and maintain the integrity of the glomerular filtration barrier. To understand the interactions between key glomerular cells such as podocytes and endothelial cells, she’s worked to develop numerous genetic mouse models that allow cell and time-specific manipulation of functional genes. Translation of her group’s findings regarding the glomerular filter reveals pathogenic mechanisms and new therapeutic targets for a number of kidney diseases, including diabetic nephropathy, nephrotic syndrome, thrombotic microangiopathies, and preeclampsia.
“My nomination for ASN Council comes at a promising time. One of many challenges but also great opportunities for advancing nephrology,” she says. “I am a committed advocate for patients and the subspecialty, working tirelessly to broaden the scope and quality of nephrology practice, fight for improvements to the American Board of Internal Medicine recertification, campaign for enhanced public and political awareness of nephrology, recommend innovations in training, and encourage translation of new discoveries to the clinic. The perspective I have on these issues is shaped by my life as a clinician and physician-scientist.”
Dr. Quaggin’s leadership roles at the American Society of Nephrology are numerous. She’s currently an editorial board member for the Journal of the American Society of Nephrology (JASN) and a cabinet member for the ASN Foundation for Kidney Research's Securing the Future Campaign, council liaison for the Diversity and Inclusion Committee and the Innovation and Discovery Task Force. In the past she’s served on the Abstract Selection Committee, (2000-2003); as Chair for the Abstract Selection Committees for Glomerular Disease, (2005, 2008) and Blood and Lymphatic Development of the Kidney, (2015), respectively; as member and Chair for the Program Committee annual meeting (2009/2013, 2014). Other service to ASN includes membership on the Public Policy Board (2016), Education Committee, (2013-2015); the Young Investigator Award Selection Committee, (2008); and the Grants Review Committee, (2006). In addition, Dr. Quaggin served as Associate Editor for JASN, (2008, 2009, 2010), and as the publication’s Deputy Editor, (2011, 2012).
She has served on the American Society of Clinical Investigation Council, ISN Executive Council, Nexus Meeting Committee, Publications Committee; and she is a standing member of the National Institute of Health’s PBKD Study Section; the Scientific Advisory Board for Aerpio Therapeutics, the Scientific Board of Governor’s of the Lowy Medical Research Institute (LMRI), the NIH Scientific Advisory Board, Diabetic Retinopathy Clinical Research Consortium; the Scientific Advisory Board for Centre de Recherches Cardiovasculaire at the Université of Descartes in Paris and is the CSO of Mannin Research.
Dr. Quaggin also now serves as Editor for Current Opinion in Nephrology & Hypertension and The Kidney, and as an Editorial Board Member for JCI, Disease Models and Mechanisms, and Kidney International.
Currently the Charles Horace Mayo professor of medicine at Northwestern University and a Finnish Distinguished Professor (2012-2017), Dr. Quaggin’s awards and honors include the International Society of Nephrology (ISN) Alfred Newton Richards Award for Basic Science, (2013); a Kidney Foundation of Canada Medal for Research Excellence, (2009); American Heart Association, Hypertension Council Donald Seldin Lecture and Award, (2012); Princesses’ Lectureship at the Victor Chang Cardiovascular Research Institute, (2013); a W. Berliner Lectureship at Yale University, (2015); a Ruth Abrahmson Visiting Lectureship, (2015); a Josh Thurman Visiting Lectureship, (2015); an Andreoli Lectureship, (2015); a Phillip A. Liverman Distinguished Lectureship, (2014); a Tisher Visiting Professor of Nephrology, (2012), a Mitch Lectureship (2016), the Shaul-Massry Visiting Professor (2017); a Gabor‐Zellerman Endowed Professorship in Renal Medicine, (2009‐2012); the University of Toronto's Department of Medicine Research Award, (2009) and William Goldie Prize in Internal Medicine, (2005); The Lloyd S.D. Fogler QC Award of Excellence, at Mount Sinai Hospital, (2004); Premier’s Research Excellence Award (PREA), (2003); and The Joe Doupe Canadian Society of Clinical Investigation Young Investigator Award, (2003). She served as Canada Research Chair in Vascular Biology from 2005 to 2010. She was elected to the American Society for Clinical Investigation in 2006 and the Association of American Physicians in 2013.